Focal adhesion kinase inhibitors, a heavy punch to cancer

Kinases are the ideal druggable targets for diseases and especially were highlighted on cancer therapy. Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase and its aberrant signaling extensively implicates in the progression of most cancer types, involving in cancer cell growth, adhesion,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yueling, Li, Ning, Ye, Chengfeng, Jiang, Xingmei, Luo, Hui, Zhang, Baoyuan, Zhang, Ying, Zhang, Qingyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777493/
https://www.ncbi.nlm.nih.gov/pubmed/35201485
http://dx.doi.org/10.1007/s12672-021-00449-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777493/
https://www.ncbi.nlm.nih.gov/pubmed/35201485
http://dx.doi.org/10.1007/s12672-021-00449-y

Ejemplares similares